Pitx2 is an upstream activator of extraocular myogenesis and survival

Developmental Biology

Volumn 349, Issue 2, 2011, Pages 395-405

  Zacharias, Amanda L ^a   Lewandoski, Mark ^b   Rudnicki, Michael A ^c,d   Gage, Philip J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Extraocular muscles; Eye development; Inducible knockout; Myogenesis; Pitx2

Indexed keywords

MYOD PROTEIN; MYOGENIC FACTOR 5; MYOGENIN; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR PITX2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EXTRAOCULAR MUSCLE; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; MESODERM; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIMORDIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION;

EID: 78650819838     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2010.10.028     Document Type: Article

References (53)

1. Abu-Elmagd M., Robson L., Sweetman D., Hadley J., Francis-West P., Munsterberg A. Wnt/Lef1 signaling acts via Pitx2 to regulate somite myogenesis. Dev. Biol. 2010, 337:211-219.
2. Bajard L., Relaix F., Lagha M., Rocancourt D., Daubas P., Buckingham M.E. A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev. 2006, 20:2450-2464.
3. Carvajal J.J., Cox D., Summerbell D., Rigby P.W. A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. Development 2001, 128:1857-1868.
4. Carvajal J.J., Keith A., Rigby P.W. Global transcriptional regulation of the locus encoding the skeletal muscle determination genes Mrf4 and Myf5. Genes Dev. 2008, 22:265-276.
5. Charles M.A., Suh H., Hjalt T.A., Drouin J., Camper S.A., Gage P.J. PITX genes are required for cell survival and Lhx3 activation. Mol. Endocrinol. 2005, 19(7):1893-1903.
6. Cheng T.C., Tseng B.S., Merlie J.P., Klein W.H., Olson E.N. Activation of the myogenin promoter during mouse embryogenesis in the absence of positive autoregulation. Proc. Natl Acad. Sci. USA 1995, 92:561-565.
7. Collins C.A., Gnocchi V.F., White R.B., Boldrin L., Perez-Ruiz A., Relaix F., Morgan J.E., Zammit P.S. Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation. PLoS ONE 2009, 4:e4475.
8. Cushman L.J., Watkins-Chow D.E., Brinkmeier M.L., Raetzman L.T., Radak A.L., Lloyd R.V., Camper S.A. Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility. Hum. Mol. Genet. 2001, 10:1141-1153.
9. Diehl A.G., Zareparsi S., Qian M., Khanna R., Angeles R., Gage P.J. Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. Invest. Ophthalmol. Vis. Sci. 2006, 47:1785-1793.
10. Dodou E., Xu S.M., Black B.L. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mech. Dev. 2003, 120:1021-1032.
11. Dong F., Sun X., Liu W., Ai D., Klysik E., Lu M.F., Hadley J., Antoni L., Chen L., Baldini A., Francis-West P., Martin J.F. Pitx2 promotes development of splanchnic mesoderm-derived branchiomeric muscle. Development 2006, 133:4891-4899.
12. Evans A.L., Gage P.J. Expression of the homeobox gene Pitx2 in neural crest is required for optic stalk and ocular anterior segment development. Hum. Mol. Genet. 2005, 14:3347-3359.
13. Evans D.J., Noden D.M. Spatial relations between avian craniofacial neural crest and paraxial mesoderm cells. Dev. Dyn. 2006, 235:1310-1325.
14. Gage P.J., Suh H., Camper S.A. Dosage requirement of Pitx2 for development of multiple organs. Development 1999, 126:4643-4651.
15. Gage P.J., Rhoades W., Prucka S.K., Hjalt T. Fate maps of neural crest and mesoderm in the mammalian eye. Invest. Ophthalmol. Vis. Sci. 2005, 46:4200-4208.
16. Gage P.J., Qian M., Wu D., Rosenberg K.I. The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development. Dev. Biol. 2008, 317:310-324.
17. Goldhamer D.J., Faerman A., Shani M., Emerson C.P. Regulatory elements that control the lineage-specific expression of myoD. Science 1992, 256:538-542.
18. Goldhamer D.J., Brunk B.P., Faerman A., King A., Shani M., Emerson C.P. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 1995, 121:637-649.
19. Grenier J., Teillet M.A., Grifone R., Kelly R.G., Duprez D. Relationship between neural crest cells and cranial mesoderm during head muscle development. PLoS ONE 2009, 4:e4381.
20. Gummow B.M., Scheys J.O., Cancelli V.R., Hammer G.D. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol. Endocrinol. 2006, 20:2711-2723.
21. Hipfner D.R., Cohen S.M. Connecting proliferation and apoptosis in development and disease. Nat. Rev. Mol. Cell Biol. 2004, 5:805-815.
22. Horst D., Ustanina S., Sergi C., Mikuz G., Juergens H., Braun T., Vorobyov E. Comparative expression analysis of Pax3 and Pax7 during mouse myogenesis. Int. J. Dev. Biol. 2006, 50:47-54.
23. Kelly R.G., Jerome-Majewska L.A., Papaioannou V.E. The del22q11.2 candidate gene Tbx1 regulates branchiomeric myogenesis. Hum. Mol. Genet. 2004, 13:2829-2840.
24. Kioussi C., Briata P., Baek S.H., Rose D.W., Hamblet N.S., Herman T., Ohgi K.A., Lin C., Gleiberman A., Wang J., Brault V., Ruiz-Lozano P., Nguyen H.D., Kemler R., Glass C.K., Wynshaw-Boris A., Rosenfeld M.G. Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 2002, 111:673-685.
25. Kitamura K., Miura H., Miyagawa-Tomita S., Yanazawa M., Katoh-Fukui Y., Suzuki R., Ohuchi H., Suehiro A., Motegi Y., Nakahara Y., Kondo S., Yokoyama M. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism. Development 1999, 126:5749-5758.
26. Kozlowski K., Walter M.A. Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders. Hum. Mol. Genet. 2000, 9:2131-2139.
27. Kuang S., Charge S.B., Seale P., Huh M., Rudnicki M.A. Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J. Cell Biol. 2006, 172:103-113.
28. Lanctot C., Moreau A., Chamberland M., Tremblay M.L., Drouin J. Hindlimb patterning and mandible development require the Ptx1 gene. Development 1999, 126:1805-1810.
29. L'Honore A., Coulon V., Marcil A., Lebel M., Lafrance-Vanasse J., Gage P., Camper S., Drouin J. Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development. Dev. Biol. 2007, 307:421-433.
30. Lin C.R., Kioussi C., O'Connell S., Briata P., Szeto D., Liu F., Izpisua-Belmonte J.C., Rosenfeld M.G. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999, 401:279-282.
31. Lu M.F., Pressman C., Dyer R., Johnson R.L., Martin J.F. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature 1999, 401:276-278.
32. Lu J.R., Bassel-Duby R., Hawkins A., Chang P., Valdez R., Wu H., Gan L., Shelton J.M., Richardson J.A., Olson E.N. Control of facial muscle development by MyoR and capsulin. Science 2002, 298:2378-2381.
33. Martin D.M., Skidmore J.M., Fox S.E., Gage P.J., Camper S.A. Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium. Dev. Biol. 2002, 252:84-99.
34. McKinnell I.W., Ishibashi J., Le Grand F., Punch V.G., Addicks G.C., Greenblatt J.F., Dilworth F.J., Rudnicki M.A. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat. Cell Biol. 2008, 10:77-84.
35. Mootoosamy R.C., Dietrich S. Distinct regulatory cascades for head and trunk myogenesis. Development 2002, 129:573-583.
36. Noden D.M., Francis-West P. The differentiation and morphogenesis of craniofacial muscles. Dev. Dyn. 2006, 235:1194-1218.
37. Patapoutian A., Miner J.H., Lyons G.E., Wold B. Isolated sequences from the linked Myf-5 and MRF4 genes drive distinct patterns of muscle-specific expression in transgenic mice. Development 1993, 118:61-69.
38. Perantoni A.O., Timofeeva O., Naillat F., Richman C., Pajni-Underwood S., Wilson C., Vainio S., Dove L.F., Lewandoski M. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development 2005, 132:3859-3871.
39. Porter J.D., Merriam A.P., Khanna S., Andrade F.H., Richmonds C.R., Leahy P., Cheng G., Karathanasis P., Zhou X., Kusner L.L., Adams M.E., Willem M., Mayer U., Kaminski H.J. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J. 2003, 17:893-895.
40. Porter J.D., Israel S., Gong B., Merriam A.P., Feuerman J., Khanna S., Kaminski H.J. Distinctive morphological and gene/protein expression signatures during myogenesis in novel cell lines from extraocular and hindlimb muscle. Physiol. Genomics 2006, 24:264-275.
41. Relaix F., Rocancourt D., Mansouri A., Buckingham M. Divergent functions of murine Pax3 and Pax7 in limb muscle development. Genes Dev. 2004, 18:1088-1105.
42. Relaix F., Rocancourt D., Mansouri A., Buckingham M. A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 2005, 435:948-953.
43. Relaix F., Montarras D., Zaffran S., Gayraud-Morel B., Rocancourt D., Tajbakhsh S., Mansouri A., Cumano A., Buckingham M. Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J. Cell Biol. 2006, 172:91-102.
44. Rinon A., Lazar S., Marshall H., Buchmann-Moller S., Neufeld A., Elhanany-Tamir H., Taketo M.M., Sommer L., Krumlauf R., Tzahor E. Cranial neural crest cells regulate head muscle patterning and differentiation during vertebrate embryogenesis. Development 2007, 134:3065-3075.
45. Ruzankina Y., Pinzon-Guzman C., Asare A., Ong T., Pontano L., Cotsarelis G., Zediak V.P., Velez M., Bhandoola A., Brown E.J. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007, 1:113-126.
46. Sambasivan R., Gayraud-Morel B., Dumas G., Cimper C., Paisant S., Kelly R.G., Tajbakhsh S. Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates. Dev. Cell 2009, 16:810-821.
47. Shih H.P., Gross M.K., Kioussi C. Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch. Proc. Natl Acad. Sci. USA 2007, 104:5907-5912.
48. Shih H.P., Gross M.K., Kioussi C. Expression pattern of the homeodomain transcription factor Pitx2 during muscle development. Gene Expr. Patterns 2007, 7:441-451.
49. Spencer R.F., Porter J.D. Biological organization of the extraocular muscles. Neuroanatomy of the Oculomotor System 2006, 43-80. Elsevier, Amsterdam, Boston. J.A. Büttner-Ennever (Ed.).
50. Suh H., Gage P.J., Drouin J., Camper S.A. Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development 2002, 129:329-337.
51. Tzahor E., Kempf H., Mootoosamy R.C., Poon A.C., Abzhanov A., Tabin C.J., Dietrich S., Lassar A.B. Antagonists of Wnt and BMP signaling promote the formation of vertebrate head muscle. Genes Dev. 2003, 17:3087-3099.
52. Yee S.P., Rigby P.W. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 1993, 7:1277-1289.
53. Zhou Y., Cheng G., Dieter L., Hjalt T.A., Andrade F.H., Stahl J.S., Kaminski H.J. An altered phenotype in a conditional knockout of Pitx2 in extraocular muscle. Invest. Ophthalmol. Vis. Sci. 2009, 50(10):4531-4541.